Daily oral Lactobacillus to reduce overactive bladder symptoms

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, placebo-controlled study randomizing participants to receive OMNi BiOTiC® 41167 or matched placebo twice daily for six months. Investigators will collect vaginal and urethral swabs and urine via a single-use catheter at baseline and follow-up visits to monitor changes in the urogenital microbiome. Symptom changes will be tracked with validated overactive bladder questionnaires and voiding diaries. The protocol seeks to link any symptom improvement to shifts in microbial communities associated with Lactobacillus supplementation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* diagnosis of overactive bladder syndrome or mixed urinary incontinence with predominance of overactive bladder symptoms

Exclusion Criteria:

* under age 18
* neurogenic overactive bladder

Where it's running

• Medical University of Vienna
  Vienna, Austria Recruiting

Study contacts

• Study coordinator: Marianne Koch
• Email: marianne.koch@meduniwien.ac.at
• Phone: +4314040029150

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Low-dose tadalafil versus solifenacin for treating overactive bladder in women

  This trial will test whether taking daily low-dose tadalafil or daily solifenacin reduces overactive bladder symptoms in women aged 18–75.

  Recruiting at 14 sites Phase 4 Mansoura University · Shibīn al Kawm, Al-Minūfiyyah and 13 other locations · NCT07416968

• Home-based remote posterior tibial nerve stimulation for overactive bladder

  This trial tests whether a home-based, app-controlled posterior tibial nerve stimulation device can reduce symptoms in adults with overactive bladder.

  Recruiting Ege University · Izmir, İzmir · NCT07081412

• Effect of tibial nerve stimulation on bladder symptoms in people with MS

  This study is testing if a new treatment using tibial nerve stimulation can help people with multiple sclerosis manage their bladder symptoms better than a placebo.

  Recruiting Imam Abdulrahman Bin Faisal University · Khobar, Eastern Providence · NCT06341673

• Improving access and adherence for overactive bladder treatment

  This study is testing a new tool to help women with overactive bladder get better access to treatment and stick with it, so they can feel better and improve their quality of life.

  Recruiting Stanford University · Redwood City, California · NCT06094543

• Comparing vaginal estradiol and oral mirabegron for overactive bladder in postmenopausal women

  This study is testing whether vaginal estradiol cream or oral mirabegron works better to help postmenopausal women with overactive bladder symptoms.

  Recruiting Phase 4 Walter Reed National Military Medical Center · Bethesda, Maryland · NCT05221021

• Comparing Emsella Chair therapy to a sham treatment for overactive bladder

  This study is testing if the Emsella Chair, a new therapy that uses electromagnetic technology, can help people with overactive bladder feel better compared to a fake treatment.

  Recruiting Corewell Health East · Royal Oak, Michigan · NCT04873037

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.